<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04312620</url>
  </required_header>
  <id_info>
    <org_study_id>ILM peeling</org_study_id>
    <nct_id>NCT04312620</nct_id>
  </id_info>
  <brief_title>Evaluation of OCT and Visual Field Changes After Vitrectomy and ILM Peeling</brief_title>
  <official_title>Evaluation of OCT and Visual Field Changes After Vitrectomy and ILM Peeling</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evulate changes in VF and OCT after viterctomy associated with ILM peeling.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Macular epiretinal membrane (ERM) is a disorder of the vitreomacular interface characterized
      by ﬁbrocellular proliferation on the anterior surface of the internal limiting membrane (ILM)
      of the macula. Pars plana vitrectomy with ERM removal and inner limiting membrane peeling is
      the standard surgical treatment for an ERM. ILM peeling is performed to eliminate the
      scaffold for myoﬁbroblast proliferation and any microscopic ERM in order to prevent ERM
      recurrence. ILM peeling is indicated for other pathologies other than ERM such as, diabetic
      macular edema, and macular hole. ILM peeling is a traumatic procedure that may have many
      effects on the underlying inner retinal layers that may lead to changes in retinal function.

      Retinal edema, eccentric scotoma, dissociation of the nerve fiber layer, iatrogenic punctuate
      chorioretinopathy, and subretinal, retinal, and vitreous hemorrhage are well described
      secondary to the surgical trauma of peeling in addition to stain toxicity. Investigation of
      these changes may assist in aiding the development of minimally traumatic techniques for ILM
      removal .

      Evaluation of functional changes may include visual field and Multifocal electroretinography
      assessment. Visual field defect after vitrectomy a well known post operative complication
      usually in eyes that underwent fluid air exchange, the cause of visual field defect remain
      unclear.

      Optical Coherence Tomography (OCT), imaging is done to evaluate inner retinal layers after
      ILM peeling,High myopic eyes might develop more severe, &quot;scattered&quot; inner retinal defects
      after ILM peeling.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 2020</start_date>
  <completion_date type="Anticipated">April 8, 2021</completion_date>
  <primary_completion_date type="Anticipated">February 9, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>BCVA</measure>
    <time_frame>6 months</time_frame>
    <description>ILM peeling</description>
  </primary_outcome>
  <enrollment type="Anticipated">10</enrollment>
  <condition>ILM Peeling</condition>
  <eligibility>
    <study_pop>
      <textblock>
        patients withIdiopathic ERM,Primary full thickness macular hole,Lamellar macular hole,
        andVitromacular traction
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. 1-Idiopathic ERM,

          2. Primary full thickness macular hole,

          3. Lamellar macular hole, and

          4. Vitromacular traction.

        Exclusion Criteria:

          -  1-Patients with a secondary ERM,

               1. diabetic retinopathy,

               2. venous occlusion,

               3. retinal detachment,

               4. uveitis, and

               5. trauma. 2-Other ocular pathologies that could interfere with the functional
                  results

               1. dense cataract ,

               2. glaucoma, and

               3. previous retinal surgery.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>almoatz bellah zohier mohamm,ed, master</last_name>
    <phone>01099490013</phone>
    <email>moatazmoh58@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>magady mostafa, professor</last_name>
  </overall_contact_backup>
  <reference>
    <citation>Noma H, Funatsu H, Sakata K, Harino S, Mimura T, Hori S. Macular microcirculation in hypertensive patients with and without branch retinal vein occlusion. Acta Ophthalmol. 2009 Sep;87(6):638-42. doi: 10.1111/j.1755-3768.2008.01318.x. Epub 2008 Jul 8.</citation>
    <PMID>18631327</PMID>
  </reference>
  <results_reference>
    <citation>Higashide T, Ohkubo S, Hangai M, Ito Y, Shimada N, Ohno-Matsui K, Terasaki H, Sugiyama K, Chew P, Li KK, Yoshimura N. Influence of Clinical Factors and Magnification Correction on Normal Thickness Profiles of Macular Retinal Layers Using Optical Coherence Tomography. PLoS One. 2016 Jan 27;11(1):e0147782. doi: 10.1371/journal.pone.0147782. eCollection 2016.</citation>
    <PMID>26814541</PMID>
  </results_reference>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>March 16, 2020</study_first_submitted>
  <study_first_submitted_qc>March 16, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 18, 2020</study_first_posted>
  <last_update_submitted>March 16, 2020</last_update_submitted>
  <last_update_submitted_qc>March 16, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 18, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Almoatz bellah zohier Mohammed</investigator_full_name>
    <investigator_title>doctor</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

